1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Patient Monitoring Market Trends
  5. > North America Cardiac Rhythm Management Market Outlook to 2020

North America Cardiac Rhythm Management Market Outlook to 2020

Summary

GlobalData’s new report, "North America Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the North America Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Cardiac Rhythm Management Devices categories - Cardiac Resynchronisation Therapy, Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.
- Annualized market revenue (USD million), volume (units) and average selling price ($) data for the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
- 2012 company shares and distribution shares data for the market category.
- Global corporate-level profiles of key companies operating within the North America Cardiac Rhythm Management Devices market.
- Key players covered include Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation and BIOTRONIK SE & Co. KG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

North America Cardiac Rhythm Management Market Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 11
2.1 What Is This Report About? 11
2.2 Cardiac Rhythm Management Market Segmentation 11
2.3 Definitions of Markets Covered in the Report 12
3 Cardiac Rhythm Management Market, North America 14
3.1 Cardiac Rhythm Management Market, North America, Revenue ($m), 2005-2020 14
3.2 Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), 2005-2020 16
3.3 Cardiac Rhythm Management Market, North America, Revenue ($m), 2005-2012 18
3.4 Cardiac Rhythm Management Market, North America, Revenue ($m), 2012-2020 20
3.5 Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020 22
3.6 Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2012 24
3.7 Cardiac Rhythm Management Market, North America, Volume (Units), 2012-2020 26
3.8 Cardiac Rhythm Management Market, North America, Company Share by Revenue ($m), 2011-2012 28
4 Cardiac Rhythm Management Market, Canada 30
4.1 Cardiac Rhythm Management Market, Canada, Revenue ($m), 2005-2012 30
4.2 Cardiac Rhythm Management Market, Canada, Revenue ($m), 2012-2020 32
4.2.1 Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), by Segment, 2005-2012 34
4.2.2 Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), by Segment, 2005-2012 36
4.2.3 Pacemakers Market, Canada, Revenue ($m), by Segment, 2005-2012 38
4.2.4 Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), by Segment, 2012-2020 40
4.2.5 Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), by Segment, 2012-2020 42
4.2.6 Pacemakers Market, Canada, Revenue ($m), by Segment, 2012-2020 44
4.3 Cardiac Rhythm Management Market, Canada, Volume (Units), 2005-2012 46
4.4 Cardiac Rhythm Management Market, Canada, Volume (Units), 2012-2020 48
4.4.1 Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), by Segment, 2005-2012 50
4.4.2 Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), by Segment, 2005-2012 52
4.4.3 Pacemakers Market, Canada, Volume (Units), by Segment, 2005-2012 54
4.4.4 Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), by Segment, 2012-2020 56
4.4.5 Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), by Segment, 2012-2020 58
4.4.6 Pacemakers Market, Canada, Volume (Units), by Segment, 2012-2020 60
4.5 Cardiac Rhythm Management Market, Canada, Average Price ($), 2005-2020 62
4.6 Cardiac Rhythm Management Market, Canada, Distribution Share by Revenue ($m), 2011-2012 64
4.7 Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), 2011-2012 65
5 Cardiac Rhythm Management Market, Mexico 67
5.1 Cardiac Rhythm Management Market, Mexico, Revenue ($m), 2005-2012 67
5.2 Cardiac Rhythm Management Market, Mexico, Revenue ($m), 2012-2020 69
5.2.1 Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), by Segment, 2005-2012 71
5.2.2 Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), by Segment, 2005-2012 73
5.2.3 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2005-2012 75
5.2.4 Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), by Segment, 2012-2020 77
5.2.5 Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), by Segment, 2012-2020 79
5.2.6 Pacemakers Market, Mexico, Revenue ($m), by Segment, 2012-2020 81
5.3 Cardiac Rhythm Management Market, Mexico, Volume (Units), 2005-2012 83
5.4 Cardiac Rhythm Management Market, Mexico, Volume (Units), 2012-2020 85
5.4.1 Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), by Segment, 2005-2012 87
5.4.2 Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), by Segment, 2005-2012 89
5.4.3 Pacemakers Market, Mexico, Volume (Units), by Segment, 2005-2012 91
5.4.4 Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), by Segment, 2012-2020 93
5.4.5 Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), by Segment, 2012-2020 95
5.4.6 Pacemakers Market, Mexico, Volume (Units), by Segment, 2012-2020 97
5.5 Cardiac Rhythm Management Market, Mexico, Average Price ($), 2005-2020 99
5.6 Cardiac Rhythm Management Market, Mexico, Distribution Share by Revenue ($m), 2011-2012 101
5.7 Cardiac Rhythm Management Market, Mexico, Company Share by Revenue ($m), 2011-2012 102
6 Cardiac Rhythm Management Market, United States 104
6.1 Cardiac Rhythm Management Market, United States, Revenue ($m), 2005-2012 104
6.2 Cardiac Rhythm Management Market, United States, Revenue ($m), 2012-2020 106
6.2.1 Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2005-2012 108
6.2.2 Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2005-2012 110
6.2.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2005-2012 112
6.2.4 Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), by Segment, 2012-2020 114
6.2.5 Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), by Segment, 2012-2020 116
6.2.6 Pacemakers Market, United States, Revenue ($m), by Segment, 2012-2020 118
6.3 Cardiac Rhythm Management Market, United States, Volume (Units), 2005-2012 120
6.4 Cardiac Rhythm Management Market, United States, Volume (Units), 2012-2020 122
6.4.1 Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2005-2012 124
6.4.2 Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2005-2012 126
6.4.3 Pacemakers Market, United States, Volume (Units), by Segment, 2005-2012 128
6.4.4 Cardiac Resynchronisation Therapy Market, United States, Volume (Units), by Segment, 2012-2020 130
6.4.5 Implantable Cardioverter Defibrillators Market, United States, Volume (Units), by Segment, 2012-2020 132
6.4.6 Pacemakers Market, United States, Volume (Units), by Segment, 2012-2020 134
6.5 Cardiac Rhythm Management Market, United States, Average Price ($), 2005-2020 136
6.6 Cardiac Rhythm Management Market, United States, Distribution Share by Revenue ($m), 2011-2012 138
6.7 Cardiac Rhythm Management Market, United States, Company Share by Revenue ($m), 2011-2012 139
7 Overview of Key Companies in North America Cardiac Rhythm Management Market 141
7.1 Medtronic, Inc. 141
7.1.1 Company Overview 141
7.2 St. Jude Medical, Inc. 141
7.2.1 Company Overview 141
7.3 Boston Scientific Corporation 141
7.3.1 Company Overview 141
7.4 Biotronik SE and Co. KG 142
7.4.1 Company Overview 142
7.5 Sorin S.p.A. 142
7.5.1 Company Overview 142
8 Cardiac Rhythm Management Market Pipeline Products 143
9 Recent Developments 144
9.1 Corporate Communications 144
9.1.1 Apr 16, 2014: Proteus Digital Health Grows Leadership Team and Board of Directors with Former Executives from Novartis, Microsoft and Egreetings Network 144
9.1.2 Apr 08, 2014: Ventripoint Corporate Update and Resignation of Director 144
9.1.3 Feb 18, 2014: SurModics Announces Changes to Board of Directors 145
9.1.4 Feb 14, 2014: Stereotaxis Appoints William C. Mills III to Chief Executive Officer 146
9.1.5 Jan 06, 2014: Catalyst Pharmaceutical Partners Reports Successful Completion of Type B Breakthrough Therapy Meeting With FDA on Firdapse Tablets Development Program 146
9.1.6 Dec 05, 2013: Anxious Patient Group Calls on NICE to Approve Only Drug Treatment for Ultra-Rare Disease 148
9.1.7 Nov 04, 2013: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis 150
9.1.8 Sep 25, 2013: Accellent Announces the Promotion of Jeremy Friedman to President and Chief Operating Officer for the Cardio and Vascular Business and the Appointment of Richard Johnson as Interim CFO 150
9.1.9 Sep 20, 2013: SurModics Announces Board Changes 151
9.1.10 Sep 16, 2013: Arena Pharmaceuticals Provides Update as Eisai's Launch of BELVIQ CIV Enters Consumer Phase 151
9.1.11 Aug 19, 2013: Orthofix Receives Expected NASDAQ Notice Related to Late Filing of Form 10-Q 152
9.1.12 Aug 16, 2013: Stereotaxis Announces Listing Transfer to NASDAQ Capital Market 152
9.1.13 Aug 02, 2013: China CDC Enters Into RandD Agreement With Aeras Global For TB Vaccine 152
9.1.14 Jul 23, 2013: Dean Schauer, Executive Vice President, Cardio and Vascular Group, Announces Resignation 154
9.1.15 Jul 02, 2013: InSite Vision Receives Notice of Allowance from USPTO for Patent on DuraSite 2 Ophthalmic Drug Delivery System 154
9.2 Financial Announcements 155
9.2.1 May 06, 2014: Stereotaxis Reports 2014 First Quarter Financial Results 155
9.2.2 May 01, 2014: SurModics Reports Second Quarter Fiscal 2014 Results 156
9.2.3 Apr 22, 2014: Bard Announces First Quarter Results 158
9.2.4 Feb 25, 2014: Stereotaxis Reports 2013 Fourth Quarter and Full Year Financial Results 158
9.2.5 Feb 18, 2014: Medtronic Reports Third Quarter Earnings 160
9.2.6 Jan 30, 2014: Bard Announces Fourth Quarter Results 162
9.2.7 Jan 30, 2014: SurModics Reports First Quarter Fiscal 2014 Results 162
9.2.8 Dec 11, 2013: Bard Declares Quarterly Dividend 164
9.2.9 Nov 19, 2013: Medtronic Reports Second Quarter Earnings 164
9.2.10 Nov 14, 2013: Stereotaxis Reports Third Quarter 2013 Financial Results 166
9.2.11 Nov 11, 2013: Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2014 167
9.2.12 Nov 07, 2013: Accellent Announces Third Quarter 2013 Results 168
9.2.13 Nov 05, 2013: SurModics Reports Fourth Quarter and Full Year 2013 Results 169
9.2.14 Oct 29, 2013: SurModics to Webcast Fourth Quarter and Fiscal Year 2013 Earnings Conference Call on November 5 171
9.2.15 Oct 23, 2013: Stereotaxis Announces Preliminary Third Quarter 2013 Financial Results in Preparation for Rights Offering 171
9.2.16 Oct 22, 2013: Bard Announces Third Quarter Results 172
9.2.17 Oct 09, 2013: Bard Declares Quarterly Dividend 172
9.2.18 Oct 01, 2013: Bard to Host Earnings Conference Call on October 22, 2013 172
9.2.19 Aug 20, 2013: Medtronic Reports First Quarter Earnings 173
9.2.20 Aug 13, 2013: Accellent Announces Second Quarter 2013 Results 174
9.2.21 Aug 12, 2013: Medtronic to Announce Financial Results for Its First Quarter of Fiscal Year 2014 176
9.2.22 Aug 08, 2013: Stereotaxis Reports Second Quarter 2013 Financial Results; Announces Capital Transactions 176
9.2.23 Aug 06, 2013: Accellent Announces Timing of Second Quarter 2013 Earnings Release and Conference Call 178
9.2.24 Jul 31, 2013: SurModics Reports Third Quarter Fiscal 2013 Results 178
9.2.25 Jul 24, 2013: Bard Announces Second Quarter Results 180
9.2.26 Jul 23, 2013: SurModics to Webcast Third Quarter 2013 Earnings Conference Call on July 31 181
9.2.27 May 21, 2013: Medtronic Reports Revenue Of $16.6 Billion In Fiscal 2013 181
9.2.28 May 14, 2013: Accellent Reports Revenue Of $120.8m In Q1 2013 183
9.3 Government and Public Interest 183
9.3.1 Jan 06, 2014: Medtronic CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference 183
9.3.2 Jan 06, 2014: Bard to Host Earnings Conference Call on January 30, 2014 183
9.3.3 Dec 20, 2013: Bard to Present at J.P. Morgan Healthcare Conference 183
9.3.4 Dec 06, 2013: Stereotaxis to Present at Oppenheimer 24th Annual Healthcare Conference in New York on December 11, 2013 183
9.3.5 Dec 04, 2013: SurModics to Present at Oppenheimer Healthcare Conference 184
9.3.6 Dec 04, 2013: Medtronic CFO Gary Ellis to Speak at Oppenheimer Healthcare Conference 184
9.3.7 Nov 26, 2013: SurModics to Present at Piper Jaffray Healthcare Conference 184
9.3.8 Nov 26, 2013: Medtronic EVP and President Mike Coyle to Speak at Piper Jaffray Healthcare Conference 184
9.4 Legal And Regulatory 184
9.4.1 Apr 11, 2014: Federal Court Orders Preliminary Injunction on U.S. Sales of Medtronic's Infringing Transcatheter Valve 184
9.4.2 Mar 12, 2014: Venaxis to Discuss Top-Line Results from Pivotal Study of APPY1 Test 185
9.4.3 Jan 22, 2014: Medtronic Statement on U.S. Supreme Court Ruling in Medtronic, Inc. v. Mirowski Family Ventures 185
9.4.4 Oct 19, 2013: Medtronic Statement on Medical Device Security 186
9.4.5 Aug 16, 2013: Glancy Binkow and Goldberg Announces Class Action Lawsuit Against Orthofix International 187
9.4.6 Aug 01, 2013: Medtronic Notifies More Than 2,700 Patients Of Lost Records 187
9.4.7 Jul 01, 2013: Bronstein, Gewirtz and Grossman, LLC Announces that a Securities Class Action has been Filed Against Medtronic, Inc. 187
9.5 Other Significant Developments 188
9.5.1 Apr 16, 2014: Bard Declares Quarterly Dividend 188
9.5.2 Feb 13, 2014: Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2014 188
9.5.3 Jan 28, 2014: Medtronic Relocates Its Regional Headquarters to Dubai 188
9.5.4 Jan 08, 2014: BIOTRONIK Devices and Leads, including latest DX System Technology, Now Available for Veterans Affairs Clients 189
9.5.5 Dec 04, 2013: Medtronic Issues $500,000 in Health Access Grants to Support Diabetes Services for the Underserved of Greater Los Angeles 189
9.5.6 Nov 27, 2013: Stereotaxis announces results of rights offering 191
9.5.7 Sep 03, 2013: SurModics Announces Organizational Changes 191
9.5.8 Aug 22, 2013: Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2014 192
9.5.9 Jul 22, 2013: SurModics to Present at the InvestMNt Conference 192
9.6 Product News 192
9.6.1 Feb 13, 2014: New Data Support Use of iRhythm's ZIO Service to Identify Cardiac Arrhythmias in Stroke and TIA Patients 192
9.6.2 Jan 27, 2014: Laerdal Medical and Wolters Kluwer Health Introduce Virtual Simulation Learning Tool for Nursing Students 193
9.6.3 Jan 02, 2014: ZIO Service Identifies Significantly More Cardiac Arrhythmias Than the Traditional Holter Monitor, According to Study Published Online in the American Journal of Medicine 194
9.6.4 Dec 20, 2013: First-in-Man Implantation of CARMAT's Bioprosthetic Artificial Heart 195
9.6.5 Nov 15, 2013: FDA Classifies Medtronic's Worldwide Voluntary Field Action on Guidewires as Class I Recall 195
9.6.6 Oct 02, 2013: Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation 196
9.6.7 Jun 25, 2013: nContact Continues To Expand Intellectual Property Portfolio For Its Multidisciplinary Approach For Treatment Of Cardiac Arrhythmias 197
9.7 Strategy And Business Planning 197
9.7.1 Sep 17, 2013: Medtronic Opens New Customer Innovation Centre in Galway, Ireland 197
9.7.2 Sep 02, 2013: Medtronic announces formation of hospital solutions business aimed at driving efficiencies 198
9.7.3 Aug 29, 2013: Medtronic To Set Up Global Center Of Excellence In Singapore For Business Model Innovation 199
10 Appendix 200
10.1 Research Methodology 201
10.1.1 Coverage 201
10.1.2 Secondary Research 201
10.1.3 Primary Research 202
10.1.4 Market Modeling and Forecasting 203
10.1.5 Company Share Analysis 206
10.1.6 Distribution Share Analysis 207
10.2 Expert Panel 207
10.3 GlobalData Consulting 208
10.4 Contact Us 208
10.5 Disclaimer 208

1.1 List of Tables
Table 1: Cardiac Rhythm Management Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 15
Table 2: Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 17
Table 3: Cardiac Rhythm Management Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 19
Table 4: Cardiac Rhythm Management Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 21
Table 5: Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020 23
Table 6: Cardiac Rhythm Management Market, North America, Volume (Units), Historic, 2005-2012 25
Table 7: Cardiac Rhythm Management Market, North America, Volume (Units), Forecast, 2012-2020 27
Table 8: Cardiac Rhythm Management Market, North America, Company Share by Revenue ($m), USD Constant, 2011-2012 29
Table 9: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 31
Table 10: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 33
Table 11: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 35
Table 12: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 37
Table 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 39
Table 14: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 41
Table 15: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 43
Table 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 45
Table 17: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012 47
Table 18: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020 49
Table 19: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Historic, 2005-2012 51
Table 20: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012 53
Table 21: Pacemakers Market, Canada, Volume (Units), Historic, 2005-2012 55
Table 22: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Forecast, 2012-2020 57
Table 23: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020 59
Table 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2012-2020 61
Table 25: Cardiac Rhythm Management Market, Canada, Average Price ($), Historic, 2005-2012 62
Table 26: Cardiac Rhythm Management Market, Canada, Average Price ($), Forecast, 2012-2020 63
Table 27: Cardiac Rhythm Management Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2011-2012 64
Table 28: Cardiac Rhythm Management Market, Canada, Company Share by Revenue ($m), USD Constant, 2011-2012 66
Table 29: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 68
Table 30: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 70
Table 31: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 72
Table 32: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 74
Table 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 76
Table 34: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 78
Table 35: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 80
Table 36: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 82
Table 37: Cardiac Rhythm Management Market, Mexico, Volume (Units), Historic, 2005-2012 84
Table 38: Cardiac Rhythm Management Market, Mexico, Volume (Units), Forecast, 2012-2020 86
Table 39: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Historic, 2005-2012 88
Table 40: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Historic, 2005-2012 90
Table 41: Pacemakers Market, Mexico, Volume (Units), Historic, 2005-2012 92
Table 42: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Forecast, 2012-2020 94
Table 43: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Forecast, 2012-2020 96
Table 44: Pacemakers Market, Mexico, Volume (Units), Forecast, 2012-2020 98
Table 45: Cardiac Rhythm Management Market, Mexico, Average Price ($), Historic, 2005-2012 99
Table 46: Cardiac Rhythm Management Market, Mexico, Average Price ($), Forecast, 2012-2020 100
Table 47: Cardiac Rhythm Management Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2011-2012 101
Table 48: Cardiac Rhythm Management Market, Mexico, Company Share by Revenue ($m), USD Constant, 2011-2012 103
Table 49: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 105
Table 50: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 107
Table 51: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 109
Table 52: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 111
Table 53: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 113
Table 54: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 115
Table 55: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 117
Table 56: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 119
Table 57: Cardiac Rhythm Management Market, United States, Volume (Units), Historic, 2005-2012 121
Table 58: Cardiac Rhythm Management Market, United States, Volume (Units), Forecast, 2012-2020 123
Table 59: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Historic, 2005-2012 125
Table 60: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Historic, 2005-2012 127
Table 61: Pacemakers Market, United States, Volume (Units), Historic, 2005-2012 129
Table 62: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Forecast, 2012-2020 131
Table 63: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Forecast, 2012-2020 133
Table 64: Pacemakers Market, United States, Volume (Units), Forecast, 2012-2020 135
Table 65: Cardiac Rhythm Management Market, United States, Average Price ($), Historic, 2005-2012 136
Table 66: Cardiac Rhythm Management Market, United States, Average Price ($), Forecast, 2012-2020 137
Table 67: Cardiac Rhythm Management Market, United States, Distribution Share by Revenue ($m), USD Constant, 2011-2012 138
Table 68: Cardiac Rhythm Management Market, United States, Company Share by Revenue ($m), USD Constant, 2011-2012 140
Table 69: Cardiac Rhythm Management Market Pipeline Products 143
Table 70 Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 203

1.2 List of Figures
Figure 1: Cardiac Rhythm Management Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2005-2020 14
Figure 2: Cardiac Rhythm Management Market, North America, Category Comparison by Revenue ($m), USD Constant, 2005-2020 16
Figure 3: Cardiac Rhythm Management Market, North America, Revenue ($m), Historic, USD Constant, 2005-2012 18
Figure 4: Cardiac Rhythm Management Market, North America, Revenue ($m), Forecast, USD Constant, 2012-2020 20
Figure 5: Cardiac Rhythm Management Market, North America, Volume (Units), 2005-2020 22
Figure 6: Cardiac Rhythm Management Market, North America, Volume (Units), Historic, 2005-2012 24
Figure 7: Cardiac Rhythm Management Market, North America, Volume (Units), Forecast, 2012-2020 26
Figure 8: Cardiac Rhythm Management Market, North America, Company Share (%), 2012 28
Figure 9: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 30
Figure 10: Cardiac Rhythm Management Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 32
Figure 11: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 34
Figure 12: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 36
Figure 13: Pacemakers Market, Canada, Revenue ($m), USD Constant, Historic, 2005-2012 38
Figure 14: Cardiac Resynchronisation Therapy Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 40
Figure 15: Implantable Cardioverter Defibrillators Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 42
Figure 16: Pacemakers Market, Canada, Revenue ($m), USD Constant, Forecast, 2012-2020 44
Figure 17: Cardiac Rhythm Management Market, Canada, Volume (Units), Historic, 2005-2012 46
Figure 18: Cardiac Rhythm Management Market, Canada, Volume (Units), Forecast, 2012-2020 48
Figure 19: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Historic, 2005-2012 50
Figure 20: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Historic, 2005-2012 52
Figure 21: Pacemakers Market, Canada, Volume (Units), Historic, 2005-2012 54
Figure 22: Cardiac Resynchronisation Therapy Market, Canada, Volume (Units), Forecast, 2012-2020 56
Figure 23: Implantable Cardioverter Defibrillators Market, Canada, Volume (Units), Forecast, 2012-2020 58
Figure 24: Pacemakers Market, Canada, Volume (Units), Forecast, 2012-2020 60
Figure 25: Cardiac Rhythm Management Market, Canada, Company Share (%), 2012 65
Figure 26: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 67
Figure 27: Cardiac Rhythm Management Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 69
Figure 28: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 71
Figure 29: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 73
Figure 30: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Historic, 2005-2012 75
Figure 31: Cardiac Resynchronisation Therapy Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 77
Figure 32: Implantable Cardioverter Defibrillators Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 79
Figure 33: Pacemakers Market, Mexico, Revenue ($m), USD Constant, Forecast, 2012-2020 81
Figure 34: Cardiac Rhythm Management Market, Mexico, Volume (Units), Historic, 2005-2012 83
Figure 35: Cardiac Rhythm Management Market, Mexico, Volume (Units), Forecast, 2012-2020 85
Figure 36: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Historic, 2005-2012 87
Figure 37: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Historic, 2005-2012 89
Figure 38: Pacemakers Market, Mexico, Volume (Units), Historic, 2005-2012 91
Figure 39: Cardiac Resynchronisation Therapy Market, Mexico, Volume (Units), Forecast, 2012-2020 93
Figure 40: Implantable Cardioverter Defibrillators Market, Mexico, Volume (Units), Forecast, 2012-2020 95
Figure 41: Pacemakers Market, Mexico, Volume (Units), Forecast, 2012-2020 97
Figure 42: Cardiac Rhythm Management Market, Mexico, Company Share (%), 2012 102
Figure 43: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 104
Figure 44: Cardiac Rhythm Management Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 106
Figure 45: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 108
Figure 46: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 110
Figure 47: Pacemakers Market, United States, Revenue ($m), USD Constant, Historic, 2005-2012 112
Figure 48: Cardiac Resynchronisation Therapy Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 114
Figure 49: Implantable Cardioverter Defibrillators Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 116
Figure 50: Pacemakers Market, United States, Revenue ($m), USD Constant, Forecast, 2012-2020 118
Figure 51: Cardiac Rhythm Management Market, United States, Volume (Units), Historic, 2005-2012 120
Figure 52: Cardiac Rhythm Management Market, United States, Volume (Units), Forecast, 2012-2020 122
Figure 53: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Historic, 2005-2012 124
Figure 54: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Historic, 2005-2012 126
Figure 55: Pacemakers Market, United States, Volume (Units), Historic, 2005-2012 128
Figure 56: Cardiac Resynchronisation Therapy Market, United States, Volume (Units), Forecast, 2012-2020 130
Figure 57: Implantable Cardioverter Defibrillators Market, United States, Volume (Units), Forecast, 2012-2020 132
Figure 58: Pacemakers Market, United States, Volume (Units), Forecast, 2012-2020 134
Figure 59: Cardiac Rhythm Management Market, United States, Company Share (%), 2012 139
Figure 60: GlobalData Epidemiology-Based Forecasting Model 205
Figure 61: GlobalData Capital Equipment-Based Forecasting Model 206
Figure 62: Primary Interviews by Participant Type (%) 207

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cardiac Rhythm Management Devices Batteries Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Cardiac Rhythm Management Devices Batteries Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Cardiac Rhythm Management (CRM) Devices Batteries Market: Overview Rising prevalence of arrhythmic patients globally have resulted in increasing number of CRM devices implantations thus, escalating ...

Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2021

Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global CM & CRM devices market is projected to reach USD 28 billion by 2021 from USD 22.19 billion in 2016, at a CAGR of 4.8% from 2016 to 2021. Growth in this market is mainly driven by factors such ...

Pacemaker Market Analysis By Product (Implantable, External), By Region And Segment Forecasts, 2014 - 2025

Pacemaker Market Analysis By Product (Implantable, External), By Region And Segment Forecasts, 2014 - 2025

  • $ 4950
  • Industry report
  • December 2016
  • by Grand View Research

The global pacemaker market is expected to reach USD 12.3 billion by 2025, according to a new report by Grand View Research, Inc. The heightening prevalence of cardiac conditions coupled with the availability ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.